141 related articles for article (PubMed ID: 20497542)
1. SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.
Huang WQ; Wang JG; Chen L; Wei HJ; Chen H
J Exp Clin Cancer Res; 2010 May; 29(1):55. PubMed ID: 20497542
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
[TBL] [Abstract][Full Text] [Related]
5. Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.
McCarthy PL; Mercer FC; Savicky MW; Carter BA; Paterno GD; Gillespie LL
Br J Cancer; 2008 Aug; 99(4):639-46. PubMed ID: 18665173
[TBL] [Abstract][Full Text] [Related]
6. T1 invasive breast lobular tumor and ductal carcinoma with HER-2 positive characteristics: Is it rationale to use adjuvant trastuzumab?
Altundag K
J BUON; 2017; 22(4):1083. PubMed ID: 28952233
[No Abstract] [Full Text] [Related]
7. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
Parton M; Krajewski S; Smith I; Krajewska M; Archer C; Naito M; Ahern R; Reed J; Dowsett M
Clin Cancer Res; 2002 Jul; 8(7):2100-8. PubMed ID: 12114409
[TBL] [Abstract][Full Text] [Related]
8. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
Muñoz M; Rosso M; Aguilar FJ; González-Moles MA; Redondo M; Esteban F
Invest New Drugs; 2008 Apr; 26(2):111-8. PubMed ID: 17906845
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
Baxter DE; Kim B; Hanby AM; Verghese ET; Sims AH; Hughes TA
Clin Breast Cancer; 2018 Dec; 18(6):481-488. PubMed ID: 30055962
[TBL] [Abstract][Full Text] [Related]
10. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
[TBL] [Abstract][Full Text] [Related]
11. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
Khurana A; Jung-Beom D; He X; Kim SH; Busby RC; Lorenzon L; Villa M; Baldi A; Molina J; Goetz MP; Shridhar V
Clin Exp Metastasis; 2013 Apr; 30(4):407-15. PubMed ID: 23412907
[TBL] [Abstract][Full Text] [Related]
12. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
[TBL] [Abstract][Full Text] [Related]
13. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.
Mackey JR; Jennings LL; Clarke ML; Santos CL; Dabbagh L; Vsianska M; Koski SL; Coupland RW; Baldwin SA; Young JD; Cass CE
Clin Cancer Res; 2002 Jan; 8(1):110-6. PubMed ID: 11801546
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608.
Rupniak NM; Carlson EJ; Shepheard S; Bentley G; Williams AR; Hill A; Swain C; Mills SG; Di Salvo J; Kilburn R; Cascieri MA; Kurtz MM; Tsao KL; Gould SL; Chicchi GG
Neuropharmacology; 2003 Aug; 45(2):231-41. PubMed ID: 12842129
[TBL] [Abstract][Full Text] [Related]
17. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
[TBL] [Abstract][Full Text] [Related]
18. FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
Xu C; Wei Q; Guo J; Zhou JC; Mei J; Jiang ZN; Shen JG; Wang LB
Ann Surg Oncol; 2015; 22(6):2034-9. PubMed ID: 25707489
[TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
20. Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.
Moriarty D; Goldhill J; Selve N; O'Donoghue DP; Baird AW
Br J Pharmacol; 2001 Aug; 133(8):1346-54. PubMed ID: 11498521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
